Dr Reddy’s launches generic lipid-regulating tablets in US Press Trust of India Apr 27, 2020 The product is a generic version of AbbVie Inc's Tricor tablets
Dr Reddy’s launches generic opioid antagonist injection in US Press Trust of India Mar 20, 2020 The product is a generic version of ADAPT Pharma Operations's Narcan injection
Dr Reddy’s launches generic Ziprasidone Mesylate for injection in US Press Trust of India Mar 19, 2020 The product is a generic version of Pfizer's Geodon injection, 20 mg/mL
Satish Reddy elected CII SR Chairman Press Trust of India Mar 13, 2020 CK Ranganathan will be the deputy The Chairman of Hyderabad-based Dr Reddy's Laboratories Satish Reddy has been elected…
Female workforce in pharma: Knocking on the glass ceiling? Tarannum Rana Mar 2, 2020 With roughly only one women out of ten professionals constituting the workforce of the Indian pharma industry, it seems that it…
Dr Reddy’s launches generic version of Vimovo tablets in US market Press Trust of India Feb 27, 2020 The drug is used to treat rheumatoid arthritis Dr Reddy's Laboratories has launched the first generic version of Vimovo…
Dr Reddy’s to acquire Wockhardt’s select generics for Rs 1850 crore Press Trust of India Feb 12, 2020 The business consists of a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS, dermatology, pain…
Pharma Budget 2020 EP News Bureau Feb 3, 2020 Pharma experts share their views and insights on the impact and implications of Budget 2020
TechMahindra and Wipro join Dr Reddy’s Laboratories on the Bloomberg Gender-Equality Index EP News Bureau Jan 22, 2020 This is the first time that three Indian companies have been included in the Bloomberg GEI, Dr Reddy’s Laboratories retains its…
Dr Reddy’s Laboratories enters nutrition segment with ‘Celevida’ in India EP News Bureau Nov 15, 2019 The brand ‘Celevida’ is derived from two words ‘celebration’ and ‘vida’, which means ‘celebrate life’. It is available in two…